Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Q1 Revenue Slides 1 Percent as Profit Jumps 27 Percent

NEW YORK, May 3 (GenomeWeb News) - Beckman Coulter today said revenues for the first quarter dipped slightly, while net income grew by over a quarter.

 

Beckman posted $560 million in revenues for the quarter ended March 31, a 1.2 percent decline from the $576 million the company earned in the same period of last year. The company attributed the decline to a change in instrument leasing policy.

 

Beckman said that it spent $55 million on R&D in the first quarter, compared to $48 million in the comparable period last year.

 

Net income for the quarter grew 27 percent to $41.4 million from $32.6 million in the year-ago period.

 

As of March 31, Beckman had $59 million in cash and cash equivalents.

 

Beckman said it expects second-quarter revenue to be between $620 million and $645 million, which would be improvements of between .3 percent and 4.4 percent above the $618.8 million the company posted for the second quarter last year.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.